210 related articles for article (PubMed ID: 29636433)
21. A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.
Humes D; Emery S; Laws E; Overbaugh J
J Virol; 2012 Dec; 86(23):12472-83. PubMed ID: 22973036
[TBL] [Abstract][Full Text] [Related]
22. Elite controllers long-term non progressors present improved survival and slower disease progression.
Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
[TBL] [Abstract][Full Text] [Related]
23. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M
Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704
[TBL] [Abstract][Full Text] [Related]
24. Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.
Pernas M; Casado C; Arcones C; Llano A; Sánchez-Merino V; Mothe B; Vicario JL; Grau E; Ruiz L; Sánchez J; Telenti A; Yuste E; Brander C; Galíndez CL
PLoS One; 2012; 7(2):e31928. PubMed ID: 22384103
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal analysis of subtype C envelope tropism for memory CD4
Gartner MJ; Gorry PR; Tumpach C; Zhou J; Dantanarayana A; Chang JJ; Angelovich TA; Ellenberg P; Laumaea AE; Nonyane M; Moore PL; Lewin SR; Churchill MJ; Flynn JK; Roche M
Retrovirology; 2020 Aug; 17(1):24. PubMed ID: 32762760
[TBL] [Abstract][Full Text] [Related]
26. Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.
Gorry PR; Ahmad F; Mohl J; Alkhatib G
AIDS; 2018 Oct; 32(16):2269-2278. PubMed ID: 30005022
[TBL] [Abstract][Full Text] [Related]
27. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.
Casado C; Colombo S; Rauch A; Martínez R; Günthard HF; Garcia S; Rodríguez C; Del Romero J; Telenti A; López-Galíndez C
PLoS One; 2010 Jun; 5(6):e11079. PubMed ID: 20552027
[TBL] [Abstract][Full Text] [Related]
28. A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.
Silver ZA; Dickinson GM; Seaman MS; Desrosiers RC
J Virol; 2019 May; 93(10):. PubMed ID: 30842322
[TBL] [Abstract][Full Text] [Related]
29. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.
Braibant M; Agut H; Rouzioux C; Costagliola D; Autran B; Barin F
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):274-84. PubMed ID: 18197126
[TBL] [Abstract][Full Text] [Related]
31. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
[TBL] [Abstract][Full Text] [Related]
32. Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.
Grovit-Ferbas K; Ferbas J; Gudeman V; Sadeghi S; Goetz MB; Giorgi JV; Chen IS; O'Brien WA
J Virol; 1998 Nov; 72(11):8650-8. PubMed ID: 9765405
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
[TBL] [Abstract][Full Text] [Related]
34. Genetically Intact but Functionally Impaired HIV-1 Env Glycoproteins in the T-Cell Reservoir.
de Verneuil A; Migraine J; Mammano F; Molina JM; Gallien S; Mouquet H; Hance AJ; Clavel F; Dutrieux J
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187544
[TBL] [Abstract][Full Text] [Related]
35. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229
[TBL] [Abstract][Full Text] [Related]
36. Elite controllers and lessons learned for HIV-1 cure.
Lopez-Galindez C; Pernas M; Casado C; Olivares I; Lorenzo-Redondo R
Curr Opin Virol; 2019 Oct; 38():31-36. PubMed ID: 31252326
[TBL] [Abstract][Full Text] [Related]
37. Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.
Etemad B; Gonzalez OA; White L; Laeyendecker O; Kirk GD; Mehta S; Sagar M
Retrovirology; 2014 Nov; 11():106. PubMed ID: 25430652
[TBL] [Abstract][Full Text] [Related]
38. Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.
Weber J; Gibson RM; Sácká L; Strunin D; Hodek J; Weberová J; Pávová M; Alouani DJ; Asaad R; Rodriguez B; Lederman MM; Quiñones-Mateu ME
AIDS Res Ther; 2017; 14():15. PubMed ID: 28331526
[TBL] [Abstract][Full Text] [Related]
39. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
[TBL] [Abstract][Full Text] [Related]
40. Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6.
Cabrera-Rodríguez R; Pérez-Yanes S; Montelongo R; Lorenzo-Salazar JM; Estévez-Herrera J; García-Luis J; Íñigo-Campos A; Rubio-Rodríguez LA; Muñoz-Barrera A; Trujillo-González R; Dorta-Guerra R; Casado C; Pernas M; Blanco J; Flores C; Valenzuela-Fernández A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
